Millennium Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$397M Buy
6,545,442
+5,801,783
+780% +$338M 0.17% 93
2025
Q4
$40.1M Sell
743,659
-1,528,633
-67% -$73.5M 0.02% 959
2025
Q3
$102M Buy
2,272,292
+2,007,944
+760% +$93.8M 0.04% 436
2025
Q2
$12.2M Sell
264,348
-289,752
-52% -$14.2M 0.01% 2050
2025
Q1
$33.8M Sell
554,100
-7,928,263
-93% -$462M 0.02% 1065
2024
Q4
$480M Buy
8,482,363
+3,296,928
+64% +$184M 0.23% 51
2024
Q3
$268M Buy
5,185,435
+3,694,795
+248% +$173M 0.13% 109
2024
Q2
$61.9M Buy
1,490,640
+1,477,680
+11,402% +$66.1M 0.03% 672
2024
Q1
$703K Sell
12,960
-2,474,633
-99% -$126M ﹤0.01% 4579
2023
Q4
$128M Buy
2,487,593
+917,745
+58% +$48.2M 0.06% 331
2023
Q3
$91.1M Sell
1,569,848
-92,131
-6% -$5.65M 0.05% 406
2023
Q2
$106M Buy
1,661,979
+9,896
+0.6% +$664K 0.05% 340
2023
Q1
$115M Buy
1,652,083
+1,496,107
+959% +$106M 0.07% 284
2022
Q4
$11.2M Buy
155,976
+125,051
+404% +$9.43M 0.01% 2004
2022
Q3
$2.2M Sell
30,925
-314,845
-91% -$22.8M ﹤0.01% 3653
2022
Q2
$26.6M Sell
345,770
-1,341,776
-80% -$102M 0.02% 1055
2022
Q1
$123M Sell
1,687,546
-1,819,552
-52% -$122M 0.07% 264
2021
Q4
$219M Buy
3,507,098
+2,370,388
+209% +$139M 0.11% 133
2021
Q3
$67.3M Sell
1,136,710
-1,104,596
-49% -$72.7M 0.04% 492
2021
Q2
$150M Sell
2,241,306
-627,710
-22% -$40.9M 0.09% 166
2021
Q1
$181M Buy
2,869,016
+59,836
+2% +$3.72M 0.13% 102
2020
Q4
$174M Sell
2,809,180
-1,543,208
-35% -$94.9M 0.13% 108
2020
Q3
$262K Buy
4,352,388
+1,401,543
+47% +$84.4M 0.32% 36
2020
Q2
$174M Buy
2,950,845
+1,795,182
+155% +$107M 0.24% 45
2020
Q1
$64.4M Buy
1,155,663
+873,406
+309% +$53.4M 0.14% 117
2019
Q4
$18.1M Sell
282,257
-139,343
-33% -$7.98M 0.02% 919
2019
Q3
$21.4M Sell
421,600
-361,324
-46% -$17M 0.03% 736
2019
Q2
$35.5M Sell
782,924
-4,537,711
-85% -$211M 0.05% 480
2019
Q1
$254M Sell
5,320,635
-1,882,341
-26% -$93.8M 0.38% 19
2018
Q4
$374M Buy
7,202,976
+4,890,444
+211% +$263M 0.58% 8
2018
Q3
$144M Buy
2,312,532
+1,754,905
+315% +$104M 0.18% 104
2018
Q2
$30.9M Sell
557,627
-2,169,186
-80% -$117M 0.04% 638
2018
Q1
$172M Buy
2,726,813
+665,890
+32% +$42.8M 0.23% 50
2017
Q4
$126M Buy
2,060,923
+18,064
+0.9% +$1.13M 0.17% 104
2017
Q3
$130M Buy
2,042,859
+1,574,086
+336% +$91.9M 0.2% 88
2017
Q2
$26.1M Sell
468,773
-325,267
-41% -$17.7M 0.05% 560
2017
Q1
$43.2M Sell
794,040
-2,780,909
-78% -$153M 0.08% 355
2016
Q4
$209M Buy
3,574,949
+1,478,257
+71% +$80.8M 0.44% 14
2016
Q3
$113M Buy
2,096,692
+1,920,595
+1,091% +$123M 0.19% 79
2016
Q2
$13M Sell
176,097
-56,243
-24% -$3.97M 0.03% 721
2016
Q1
$14.8M Sell
232,340
-1,468,702
-86% -$92.6M 0.04% 617
2015
Q4
$117M Buy
1,701,042
+605,943
+55% +$40M 0.25% 58
2015
Q3
$64.8M Buy
1,095,099
+952,628
+669% +$60.4M 0.13% 172
2015
Q2
$9.48M Sell
142,471
-1,193,515
-89% -$78.7M 0.02% 1013
2015
Q1
$86.2M Buy
+1,335,986
New +$83.6M 0.16% 118
2014
Q4
Sell
-51,141
Closed -$2.88M 3918
2014
Q3
$2.62M Sell
51,141
-252,100
-83% -$12.6M 0.01% 1690
2014
Q2
$14.7M Sell
303,241
-138,299
-31% -$6.82M 0.04% 627
2014
Q1
$22.9M Sell
441,540
-1,614,176
-79% -$85.9M 0.07% 389
2013
Q4
$109M Buy
2,055,716
+2,020,716
+5,773% +$103M 0.34% 28
2013
Q3
$1.62M Sell
35,000
-285,781
-89% -$12.5M 0.01% 1817
2013
Q2
$14.3M Buy
+320,781
New +$13.9M 0.04% 451

Other funds holding BMY

Millennium Management's BMY Position: Q1 2026 in Review

Millennium Management increased its Bristol-Myers Squibb (BMY) stake by 780% in Q1 2026, buying an estimated $338M and bringing the position to 6,545,442 shares worth $397M. The position accounts for 0.17% of the portfolio, ranked #93.

Millennium Management first reported a position in BMY in Q2 2013 and has held it in 51 quarters since. The position peaked at $480M in Q4 2024. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Millennium Management held 6,545,442 shares of Bristol-Myers Squibb worth $397M as of Q1 2026.
  • Millennium Management bought 5,801,783 Bristol-Myers Squibb shares in Q1 2026, an estimated $338M.
  • Bristol-Myers Squibb made up 0.17% of Millennium Management's portfolio in Q1 2026, its #93 holding.
  • Millennium Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 51 quarters since.
  • Millennium Management's Bristol-Myers Squibb position peaked at $480M in Q4 2024.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.